No abstract available
MeSH terms
-
Anaplastic Lymphoma Kinase
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Non-Small-Cell Lung / diagnosis
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / genetics
-
Clinical Trials as Topic
-
Crizotinib
-
Humans
-
Lung Neoplasms / diagnosis
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / genetics
-
Medical Oncology / legislation & jurisprudence*
-
Medical Oncology / organization & administration
-
Medical Oncology / trends
-
Molecular Diagnostic Techniques
-
Mutation / physiology
-
Practice Guidelines as Topic*
-
Prognosis
-
Protein Kinase Inhibitors / administration & dosage
-
Pyrazoles / administration & dosage*
-
Pyridines / administration & dosage*
-
Receptor Protein-Tyrosine Kinases / genetics
-
Societies, Medical / legislation & jurisprudence
Substances
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Pyridines
-
Crizotinib
-
Anaplastic Lymphoma Kinase
-
Receptor Protein-Tyrosine Kinases